Olanzapine is an oral tablet used in the treatment of depression, schizophrenia and bipolar I disorder. It is available as an orally disintegrating tablet which dissolves quickly in the mouth and a tablet. The side effects related to olanzapine are difficulty in swallowing, dizziness, headache, feeling tired or restless, and drowsiness. Olanzapine is also used along with fluoxetine for the treatment of depression in adults and children at least 10 years old who have bipolar I disorder. Expansion of the olanzapine market size is propelled by surge in the population with schizophrenia of several nations, such as China and Japan. As the global population rise, individuals do not get complete nutrition for kids, which result in increase in occurrence of schizophrenia. Apart from this, the rise in government support for healthcare infrastructure advances further fuels the olanzapine market growth. Additionally, growth in the dysfunctional behavior among people contributes toward the expansion of the market. However, the adverse affects of the drugs used by people may hamper the market growth. The Olanzapine Market is likely to grow at a rate of 2.1% CAGR by 2027.

Olanzapine Market by Application

Bipolar Disorder

Others

Schizophrenia

Olanzapine Market by Route of Administration

Oral

Parenteral

Olanzapine Market by Distribution Channel

Hospital Pharmacies

Drug stores and Retail Pharmacies

Online Providers

Olanzapine Market by Geography

North America

Europe

Asia Pacific

Rest of the World

On the basis of application, the market for Olanzapine is classified into Bipolar Disorder, Others and Schizophrenia. The Schizophrenia segment type is anticipated to hold the greatest share in the market. The factor which propels the growth of the segment is an increase in incidences of mental illness. For example, as per the National Institute of Mental Health (NIH) in the U.S., 52.9 million adults lived with mental illness in 2020. Therefore, a rise in incidences of mental illness, which needs olanzapine medication as a treatment to treat the disease, accelerates market growth.

Further, the market is based on Route of Administration, which is furcated into Oral and Parenteral. Compared to parenteral the oral route of administration segment is having the significant share in the market. This can be ascribed to the increased adoption of oral drugs owing to high patient compliance, noninvasive, convenient to handle, and not needing any specific sterile conditions. For example, the Sun Pharmaceutical Industries Ltd. provides oral olanzapine tablets.

Based on the market for distribution channel, the market is segmented into Hospital Pharmacies, Drug stores and Retail Pharmacies and Online Providers. The Drug stores and Retail Pharmacies are projected to capture the maximum share in the market. The easy availability of olanzapine drugs in the Drug stores and Retail Pharmacies is the key reason for the segment growth.

As per the geographical analysis, the olanzapine market is segregated as North America, Europe, Asia Pacific and Rest of the World. North America has the significant share in the market. This is owing to the universal usage of the product by patients in the region and leading manufacturers creating the product in the region.

Globally, the incidence of bipolar treatment is a vital driver of the olanzapine market growth. There is no exact medication available for the olanzapine disorder. Factors such as disturbing thoughts, loss of interest in life, abnormal emotions are few of the symptoms of olanzapine. These disorders are same to depression. The more availability of bipolar treatment is fueling more demand for the global olanzapine market. Therefore, it fuels the global olanzapine market growth.

Few notable vendors of the olanzapine market are Alkermes, Inc., Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Limited, Aurobindo Pharma Ltd, Eli Lilly and Company, apotex inc., Dr. Reddy's Laboratories Ltd., Torrent Group, Novartis AG, and Viatris

Henceforth, the schizophrenia, bipolar and other mental disorders are considered as a serious condition across the world, regardless of age, gender and other factors. There is no proper treatment for these conditions but, the olanzapine is considered to have to have significant role in controlling the symptoms of mental disorders.

The several factors are included in the study which are impacting the market growth and restricting the market.

This report consists of the segmentations and sub segmentations and the segment’s contribution to the market growth.

The report further covers the profiles of the key vendors in market coupled with their strategies such as product launches, company expansions and acquisitions.

Further, the report depicts the penetration of the market in the various regions.

1. Executive Summary

2. Industry Outlook

2.1. Industry Overview

2.2. Industry Trends

3. Market Snapshot

3.1. Market Definition

3.2. Market Outlook

3.2.1. Porter Five Forces

3.3. Related Markets

4. Market characteristics

4.1. Market Overview

4.2. Market Segmentation

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. DRO - Impact Analysis

5. Application: Market Size & Analysis

5.1. Overview

5.2. Bipolar Disorder

5.3. Others

5.4. Schizophrenia

6. Route of Administration: Market Size & Analysis

6.1. Overview

6.2. Oral

6.3. Parenteral

7. Distribution Channel: Market Size & Analysis

7.1. Overview

7.2. Hospital Pharmacies

7.3. Drug stores and Retail Pharmacies

7.4. Online Providers

8. Geography: Market Size & Analysis

8.1. Overview

8.2. North America

8.3. Europe

8.4. Asia Pacific

8.5. Rest of the World

9. Competitive Landscape

9.1. Competitor Comparison Analysis

9.2. Market Developments

9.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships

9.2.2. Product Launches and execution

10. Vendor Profiles

10.1. Alkermes, Inc.

10.1.1. Overview

10.1.2. Financial Overview

10.1.3. Product Offerings

10.1.4. Developments

10.1.5. Business Strategy

10.2. Sun Pharmaceutical Industries Limited

10.2.1. Overview

10.2.2. Financial Overview

10.2.3. Product Offerings

10.2.4. Developments

10.2.5. Business Strategy

10.3. Teva Pharmaceutical Industries Limited

10.3.1. Overview

10.3.2. Financial Overview

10.3.3. Product Offerings

10.3.4. Developments

10.3.5. Business Strategy

10.4. Aurobindo Pharma Ltd

10.4.1. Overview

10.4.2. Financial Overview

10.4.3. Product Offerings

10.4.4. Developments

10.4.5. Business Strategy

10.5. Eli Lilly and Company

10.5.1. Overview

10.5.2. Financial Overview

10.5.3. Product Offerings

10.5.4. Developments

10.5.5. Business Strategy

10.6. apotex inc.

10.6.1. Overview

10.6.2. Financial Overview

10.6.3. Product Offerings

10.6.4. Developments

10.6.5. Business Strategy

10.7. Dr. Reddy's Laboratories Ltd.

10.7.1. Overview

10.7.2. Financial Overview

10.7.3. Product Offerings

10.7.4. Developments

10.7.5. Business Strategy

10.8. Torrent Group

10.8.1. Overview

10.8.2. Financial Overview

10.8.3. Product Offerings

10.8.4. Developments

10.8.5. Business Strategy

10.9. Novartis AG

10.9.1. Overview

10.9.2. Financial Overview

10.9.3. Product Offerings

10.9.4. Developments

10.9.5. Business Strategy

10.10. Viatris

10.10.1. Overview

10.10.2. Financial Overview

10.10.3. Product Offerings

10.10.4. Developments

10.10.5. Business Strategy

11. Analyst Opinion

12. Annexure

12.1. Report Scope

12.2. Market Definitions

12.3. Research Methodology

12.3.1. Data Collation and In-house Estimation

12.3.2. Market Triangulation

12.3.3. Forecasting

12.4. Report Assumptions

12.5. Declarations

12.6. Stakeholders

12.7. Abbreviations

TABLE 1. GLOBAL OLANZAPINE MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)

TABLE 2. GLOBAL OLANZAPINE MARKET VALUE FOR BIPOLAR DISORDER, BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 3. GLOBAL OLANZAPINE MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 4. GLOBAL OLANZAPINE MARKET VALUE FOR SCHIZOPHRENIA, BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 5. GLOBAL OLANZAPINE MARKET VALUE, BY ROUTE OF ADMINISTRATION, BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 6. GLOBAL OLANZAPINE MARKET VALUE FOR ORAL, BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 7. GLOBAL OLANZAPINE MARKET VALUE FOR PARENTERAL, BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 8. GLOBAL OLANZAPINE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)

TABLE 9. GLOBAL OLANZAPINE MARKET VALUE FOR HOSPITAL PHARMACIES, BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 10. GLOBAL OLANZAPINE MARKET VALUE FOR DRUG STORES AND RETAIL PHARMACIES, BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 11. GLOBAL OLANZAPINE MARKET VALUE FOR ONLINE PROVIDERS, BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 12. NORTH AMERICA OLANZAPINE MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)

TABLE 13. NORTH AMERICA OLANZAPINE MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)

TABLE 14. NORTH AMERICA OLANZAPINE MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)

TABLE 15. NORTH AMERICA OLANZAPINE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)

TABLE 16. U.S OLANZAPINE MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)

TABLE 17. U.S OLANZAPINE MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)

TABLE 18. U.S OLANZAPINE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)

TABLE 19. CANADA OLANZAPINE MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)

TABLE 20. CANADA OLANZAPINE MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)

TABLE 21. CANADA OLANZAPINE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)

TABLE 22. EUROPE OLANZAPINE MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)

TABLE 23. EUROPE OLANZAPINE MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)

TABLE 24. EUROPE OLANZAPINE MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)

TABLE 25. EUROPE OLANZAPINE MARKET VALUE, DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)

TABLE 26. GERMANY OLANZAPINE MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)

TABLE 27. GERMANY OLANZAPINE MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)

TABLE 28. GERMANY OLANZAPINE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)

TABLE 29. U.K OLANZAPINE MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)

TABLE 30. U.K OLANZAPINE MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)

TABLE 31. U.K OLANZAPINE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)

TABLE 32. FRANCE OLANZAPINE MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)

TABLE 33. FRANCE OLANZAPINE MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)

TABLE 34. FRANCE OLANZAPINE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)

TABLE 35. ITALY OLANZAPINE MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)

TABLE 36. ITALY OLANZAPINE MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)

TABLE 37. ITALY OLANZAPINE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)

TABLE 38. SPAIN OLANZAPINE MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)

TABLE 39. SPAIN OLANZAPINE MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)

TABLE 40. SPAIN OLANZAPINE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)

TABLE 41. ROE OLANZAPINE MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)

TABLE 42. ROE OLANZAPINE MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)

TABLE 43. ROE OLANZAPINE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)

TABLE 44. ASIA PACIFC OLANZAPINE MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)

TABLE 45. ASIA PACIFC OLANZAPINE MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)

TABLE 46. ASIA PACIFC OLANZAPINE MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)

TABLE 47. ASIA PACIFC OLANZAPINE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)

TABLE 48. CHINA OLANZAPINE MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)

TABLE 49. CHINA OLANZAPINE MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)

TABLE 50. CHINA OLANZAPINE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)

TABLE 51. INDIA OLANZAPINE MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)

TABLE 52. INDIA OLANZAPINE MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)

TABLE 53. INDIA OLANZAPINE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)

TABLE 54. JAPAN OLANZAPINE MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)

TABLE 55. JAPAN OLANZAPINE MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)

TABLE 56. JAPAN OLANZAPINE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)

TABLE 57. REST OF APAC OLANZAPINE MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)

TABLE 58. REST OF APAC OLANZAPINE MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)

TABLE 59. REST OF APAC OLANZAPINE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)

TABLE 60. REST OF WORLD OLANZAPINE MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)

TABLE 61. REST OF WORLD OLANZAPINE MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)

TABLE 62. REST OF WORLD OLANZAPINE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)

TABLE 63. ALKERMES, INC.: FINANCIALS

TABLE 64. ALKERMES, INC.: PRODUCTS & SERVICES

TABLE 65. ALKERMES, INC.: RECENT DEVELOPMENTS

TABLE 66. SUN PHARMACEUTICAL INDUSTRIES LIMITED: FINANCIALS

TABLE 67. SUN PHARMACEUTICAL INDUSTRIES LIMITED: PRODUCTS & SERVICES

TABLE 68. SUN PHARMACEUTICAL INDUSTRIES LIMITED: RECENT DEVELOPMENTS

TABLE 69. TEVA PHARMACEUTICAL INDUSTRIES LIMITED: FINANCIALS

TABLE 70. TEVA PHARMACEUTICAL INDUSTRIES LIMITED: PRODUCTS & SERVICES

TABLE 71. TEVA PHARMACEUTICAL INDUSTRIES LIMITED: RECENT DEVELOPMENTS

TABLE 72. AUROBINDO PHARMA LTD: FINANCIALS

TABLE 73. AUROBINDO PHARMA LTD: PRODUCTS & SERVICES

TABLE 74. AUROBINDO PHARMA LTD: RECENT DEVELOPMENTS

TABLE 75. ELI LILLY AND COMPANY: FINANCIALS

TABLE 76. ELI LILLY AND COMPANY: PRODUCTS & SERVICES

TABLE 77. ELI LILLY AND COMPANY: RECENT DEVELOPMENTS

TABLE 78. APOTEX INC.: FINANCIALS

TABLE 79. APOTEX INC.: PRODUCTS & SERVICES

TABLE 80. APOTEX INC.: RECENT DEVELOPMENTS

TABLE 81. DR. REDDY'S LABORATORIES LTD.: FINANCIALS

TABLE 82. DR. REDDY'S LABORATORIES LTD.: PRODUCTS & SERVICES

TABLE 83. DR. REDDY'S LABORATORIES LTD.: RECENT DEVELOPMENTS

TABLE 84. TORRENT GROUP: FINANCIALS

TABLE 85. TORRENT GROUP: PRODUCTS & SERVICES

TABLE 86. TORRENT GROUP: RECENT DEVELOPMENTS

TABLE 87. NOVARTIS AG: FINANCIALS

TABLE 88. NOVARTIS AG: PRODUCTS & SERVICES

TABLE 89. NOVARTIS AG: RECENT DEVELOPMENTS

TABLE 90. VIATRIS: FINANCIALS

TABLE 91. VIATRIS: PRODUCTS & SERVICES

TABLE 92. VIATRIS: RECENT DEVELOPMENTS

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)